Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.024 | 0.9 |